Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Debt to Equity Ratio: 1.326 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.326 |
| June 30, 2024 | 1.342 |
| March 31, 2024 | 1.308 |
| December 31, 2023 | 1.232 |
| September 30, 2023 | 1.137 |
| June 30, 2023 | 3.888 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
3.888
Maximum
Jun 2023
0.7309
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Arcutis Biotherapeutics Inc | 1.306 |
| Cytokinetics Inc | -47.16 |
| Amicus Therapeutics Inc | 2.178 |
| MannKind Corp | -1.086 |
| TG Therapeutics Inc | 1.271 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 667.89M |
| Total Liabilities (Quarterly) | 435.87M |
| Shareholders Equity (Quarterly) | 232.02M |
| Current Ratio | 3.340 |
| Net Debt Paydown Yield | -0.02% |